Today: 24 April 2026
Palantir shares jump on fresh $200 target as Thiel sale plan keeps traders edgy
4 March 2026
2 mins read

Palantir shares jump on fresh $200 target as Thiel sale plan keeps traders edgy

NEW YORK, March 4, 2026, 07:57 EST

  • Palantir shares picked up roughly 1.4% in premarket action
  • Rosenblatt upped its price target to $200, previously $150, while sticking with its buy rating
  • U.S. defense AI policy changes are drawing investor attention after fresh restrictions landed on rival technologies.

Shares of Palantir Technologies Inc climbed roughly 1.4% ahead of the open on Wednesday, after Rosenblatt Securities bumped its price target on the data analytics company to $200, up from $150. The firm maintained its buy rating.

The call came while the Pentagon was reassessing its approach to purchasing and deploying commercial AI, following a senior official’s warning that certain contract terms might lock down tools during combat planning. Large language models—AI trained on vast text datasets—can respond to prompts by generating answers and plans.

The vendor roster is under pressure now, too. Defense contractors are moving to drop Anthropic’s Claude, following President Donald Trump’s directive for a government-wide phase-out. The Pentagon has also labeled the company a supply-chain risk. Still, some attorneys argue the wider ban on contractors could face legal hurdles.

Reuters reported Monday that the U.S. State Department, Treasury, and Health and Human Services instructed employees to discontinue using Anthropic’s products, directing them to use alternatives including OpenAI’s ChatGPT and Google’s Gemini instead.

Palantir’s bread and butter has been government and defense contracts for years. Back in July, the U.S. Army announced plans to consolidate a slew of software deals into one enterprise contract with Palantir, potentially valued at $10 billion across a decade. Still, the Army emphasized there are no guaranteed new buys in the agreement.

Insider selling cropped up again this week. According to a Form 144 filing the SEC logged late Monday, STS Holdings II LLC—controlled by Palantir co-founder Peter Thiel—put forward plans to unload as many as 2 million Class A shares, with the total market value pegged at roughly $280 million.

Executives at the company aren’t mincing words. “If you have ever considered returning to Palantir, this is the week to do it,” Ted Mabrey, Palantir’s global head of commercial, wrote in a post, adding a Tolkien reference for alumni: “The Shire is calling.” Business Insider

Guardian Premier Solutions, a defense contractor based in San Antonio, has taken Palantir to Texas state court, accusing the company of fraud and breach of contract over a partnership program that, according to the local report, cost roughly $709,000 and failed to deliver the business referrals it promised. The report also noted that Palantir hadn’t filed a response to the suit.

Traders are eyeing whether Washington’s stricter contract guardrails mean more projects for integrators such as Palantir. Another read: the spending might just favor model providers and cloud players already wired into government channels.

Still, risks stand out. Should the Anthropic ban get rolled back or limited, the procurement shift might lose steam, and Palantir’s lofty valuation doesn’t tolerate much misstep. Defense-focused gainers often see a quick pullback from investors once the story quiets down.

Stock Market Today

  • Options Market Signals Potential Volatility for Rigel Pharmaceuticals Stock
    April 24, 2026, 10:20 AM EDT. Investors should note elevated implied volatility in Rigel Pharmaceuticals' (RIGL) June 2026 $23 call option, indicating expectations of significant price movement. Implied volatility reflects market anticipation of stock fluctuations, often linked to upcoming events. Despite this, Rigel holds a Zacks Rank #3 (Hold) with mixed analyst sentiment; earnings estimates for the current quarter were slightly lowered from 90 to 86 cents per share. This divergence suggests options traders may be employing premium selling strategies, betting that the stock's movement may not meet the high volatility priced in. The situation warrants close observation for investors considering exposure to Rigel Pharmaceuticals.

Latest article

Joby Aviation’s LA Air Taxi Bet Gets a Rooftop Test as Investors Watch Certification

Joby Aviation’s LA Air Taxi Bet Gets a Rooftop Test as Investors Watch Certification

24 April 2026
Reuben Brothers and Joby Aviation announced plans for an air-taxi vertiport at Park Elm Residences at Century Plaza in Los Angeles, using the South Tower’s helipad and adding charging and a passenger lounge. The project requires local, state, and federal approvals. Joby is still seeking commercial certification for its electric aircraft. Residents would be able to book flights within the Los Angeles area.
MaxLinear Stock Jumps 67% as AI Data-Center Demand Powers Outlook

MaxLinear Stock Jumps 67% as AI Data-Center Demand Powers Outlook

24 April 2026
MaxLinear shares jumped 67% to $57.30 in early Friday trading after first-quarter revenue rose 43% to $137.2 million, beating estimates. The company projected second-quarter revenue of $160 million to $170 million, citing strong demand for optical data-center chips used in AI infrastructure.
Qualcomm Stock Jumps Before April 29 Earnings, But the AI Trade Has a Hard Test Ahead

Qualcomm Stock Jumps Before April 29 Earnings, But the AI Trade Has a Hard Test Ahead

24 April 2026
Qualcomm shares surged 9.7% to $146.97 in early Friday trading ahead of its April 29 earnings report. The company forecasts fiscal Q2 revenue of $10.2–$11 billion and adjusted EPS of $2.45–$2.65, with handset chip sales near $6 billion. JPMorgan downgraded the stock, citing smartphone headwinds and data-center competition. Adobe traded nearly flat at $238.76 after a large buyback.
FDA hits Novo Nordisk with another Ozempic ad warning — second strike in weeks
Previous Story

FDA hits Novo Nordisk with another Ozempic ad warning — second strike in weeks

Petrobras won’t rush Brazil fuel price changes after Iran conflict spikes oil, CEO says
Next Story

Petrobras won’t rush Brazil fuel price changes after Iran conflict spikes oil, CEO says

Go toTop